CRNX CRINETICS PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Management Change Crinetics Pharmaceuticals announced that Chief Commercial Officer James Hassard will leave the company effective October 14, 2024, and will receive termination benefits as per his employment agreement.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC